AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 247: R29-R33, 1984;
0363-6119/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, R.
Right arrow Articles by Genest, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, R.
Right arrow Articles by Genest, J.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 247, Issue 1 29-R33, Copyright © 1984 by American Physiological Society


ARTICLES

Lymphatic, renal, and urinary kallikreins in the rat

R. Garcia, G. Thibault and J. Genest

In pentobarbital-anesthetized rats the lymphatic vessels next to the renal artery and the urinary bladder were cannulated and lymph and urine were collected for 3 h. The kidneys were then washed and removed. Four experimental groups were studied. Kallikrein was measured in lymph, urine, and kidney extracts by a direct radioimmunoassay. Immunoreactive renal and urinary kallikreins were higher in a Na-deficient group. No changes were brought about by furosemide administration or Na supplementation. A very low concentration of immunoreactive kallikrein was found in lymph, with no differences between the groups. In the same urine and kidney extract samples, both total (trypsin-activated) kallikrein and naturally active kallikrein were determined as kininogenase activity in the rat uterus bioassay. Both active and inactive kallikreins were found in kidney and urine, but most of the changes induced by a Na-deficient diet or furosemide administration were restricted to the active form. It is suggested that the lymphatic route in the kidney is probably not an important source of circulating immunoreactive glandular kallikrein.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online